Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.34 | 0.06 |
mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.33 | 0.05 |
mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.31 | 0.07 |
mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.31 | 0.1 |
mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.29 | 0.09 |
mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |